BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

7:05 PM
 | 
Sep 23, 2008
 |  BC Extra  |  Company News

Nerveda acquires DioGenix

Nerveda (San Diego, Calif.) purchased Ore's DioGenix molecular diagnostics subsidiary for $1.3 million in cash. DioGenix's lead product, a blood-based molecular diagnostic for...

Read the full 100 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >